NLS Pharmaceutics Looks to Raise $0.79M via Securities Offering

Seeking AlphaJun 28 09:34 ET

NLS Pharmaceutics Announces Publication Of New Patent Application For Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists With The World Intellectual Property Organization

BenzingaJun 11 08:35 ET

6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementJun 6 17:02 ET · Announcements

NLS Pharmaceutics Reports Results From Study KO-874 On Mazindol's Neuroprotective Effects In Narcoleptic-Like Rat Model

BenzingaMay 28 08:07 ET

20-F: Registration statement / Annual report / Transition report

SEC announcementMay 15 22:33 ET · Announcements

NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event

AccesswireMar 14 08:00 ET